CI
Cigna Group
Company overview
- Market capitalization
- $71.83B
- Employees
- 65,669
- Latest publication
- 2026-09-29
About Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20252025-12-31 · USD | Q3 20222022-09-30 · USD | Q2 20222022-06-30 · USD | Q3 20212021-09-30 · USD | Q2 20212021-06-30 · USD | Q1 20212021-03-31 · USD | Q4 20202020-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 71,668,000,000USD | 72,472,000,000USD | 45,281,000,000USD | 45,478,000,000USD | 44,288,000,000USD | 43,131,000,000USD | 40,971,000,000USD | 41,712,000,000USD |
| Cost Of Revenue | 56,703,000,000USD | 66,918,000,000USD | 39,528,000,000USD | 39,342,000,000USD | 38,400,000,000USD | 37,485,000,000USD | 35,240,000,000USD | 35,906,000,000USD |
| Gross Profit | 14,965,000,000USD | 5,554,000,000USD | 5,753,000,000USD | 6,136,000,000USD | 5,888,000,000USD | 5,646,000,000USD | 5,731,000,000USD | 5,806,000,000USD |
| Selling General Administrative | 3,470,000,000USD | 3,406,000,000USD | 3,124,000,000USD | 3,256,000,000USD | 3,080,000,000USD | 2,996,000,000USD | 3,279,000,000USD | 3,398,000,000USD |
| Other Operating Expenses | 8,430,000,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 12,289,000,000USD | 3,406,000,000USD | 3,611,000,000USD | 3,765,000,000USD | 3,594,000,000USD | 3,499,000,000USD | 3,774,000,000USD | 4,461,000,000USD |
| Operating Income | 2,676,000,000USD | 2,148,000,000USD | 2,142,000,000USD | 2,371,000,000USD | 2,294,000,000USD | 2,147,000,000USD | 1,957,000,000USD | 1,345,000,000USD |
| Total Other Income Expense Net | -419,000,000USD | -519,000,000USD | 1,349,000,000USD | -390,000,000USD | -235,000,000USD | -249,000,000USD | -444,000,000USD | 4,033,000,000USD |
| Interest Expense | 356,000,000USD | 335,000,000USD | 304,000,000USD | 301,000,000USD | 303,000,000USD | 298,000,000USD | 314,000,000USD | 337,000,000USD |
| Depreciation And Amortization | 389,000,000USD | 580,000,000USD | 726,000,000USD | 759,000,000USD | 734,000,000USD | 731,000,000USD | 715,000,000USD | 713,000,000USD |
| Income Before Tax | 2,257,000,000USD | 1,629,000,000USD | 3,491,000,000USD | 1,981,000,000USD | 2,059,000,000USD | 1,898,000,000USD | 1,513,000,000USD | 5,378,000,000USD |
| Income Tax Expense | 382,000,000USD | 395,000,000USD | 713,000,000USD | 411,000,000USD | 424,000,000USD | 422,000,000USD | 342,000,000USD | 1,236,000,000USD |
| Net Income | 1,875,000,000USD | 1,234,000,000USD | 2,757,000,000USD | 1,557,000,000USD | 1,621,000,000USD | 1,467,000,000USD | 1,161,000,000USD | 4,135,000,000USD |
| Minority Interest | 215,000,000USD | -40,000,000USD | 21,000,000USD | 13,000,000USD | 14,000,000USD | 58,000,000USD | 10,000,000USD | 7,000,000USD |
| Net Income Applicable To Common Shares | 1,660,000,000USD | 1,234,000,000USD | 2,757,000,000USD | 1,559,000,000USD | 1,621,000,000USD | 1,467,000,000USD | 1,161,000,000USD | 4,135,000,000USD |
| Interest Income | — | 462,000,000USD | 304,000,000USD | 301,000,000USD | 303,000,000USD | 298,000,000USD | 314,000,000USD | 337,000,000USD |
| Net Interest Income | — | -362,000,000USD | -304,000,000USD | -301,000,000USD | -303,000,000USD | -298,000,000USD | -314,000,000USD | -337,000,000USD |
| Tax Provision | — | 543,000,000USD | 713,000,000USD | 413,000,000USD | 424,000,000USD | 422,000,000USD | 342,000,000USD | 1,236,000,000USD |
| Net Income From Continuing Ops | — | 1,274,000,000USD | 2,778,000,000USD | 1,572,000,000USD | 1,635,000,000USD | 1,476,000,000USD | 1,171,000,000USD | 4,142,000,000USD |
| Ebit | — | 1,964,000,000USD | 2,149,000,000USD | 2,384,000,000USD | 2,286,000,000USD | 2,143,000,000USD | 1,936,000,000USD | 1,517,000,000USD |
| Ebitda | — | 2,544,000,000USD | 2,875,000,000USD | 3,143,000,000USD | 3,020,000,000USD | 2,874,000,000USD | 2,651,000,000USD | 2,230,000,000USD |
| Reconciled Depreciation | — | 722,000,000USD | 726,000,000USD | 759,000,000USD | 734,000,000USD | 731,000,000USD | 715,000,000USD | 713,000,000USD |
| Unclassified Operating Expenses | — | — | 487,000,000USD | 509,000,000USD | 514,000,000USD | 503,000,000USD | 495,000,000USD | 495,000,000USD |
| Non Operating Income Net Other | — | — | 1,431,000,000USD | -301,000,000USD | -303,000,000USD | -308,000,000USD | -445,000,000USD | 3,866,000,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 568,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Total Revenue | 140,162,000,000USD |
| Cost Of Revenue | 110,803,000,000USD |
| Gross Profit | 29,359,000,000USD |
| Selling General Administrative | 7,192,000,000USD |
| Other Operating Expenses | 16,354,000,000USD |
| Total Operating Expenses | 24,325,000,000USD |
| Operating Income | 5,034,000,000USD |
| Total Other Income Expense Net | -507,000,000USD |
| Interest Expense | 713,000,000USD |
| Depreciation And Amortization | 779,000,000USD |
| Income Before Tax | 4,527,000,000USD |
| Income Tax Expense | 791,000,000USD |
| Net Income | 3,736,000,000USD |
| Minority Interest | 422,000,000USD |
| Net Income Applicable To Common Shares | 3,314,000,000USD |
| Source | DisclosureDeterministicFinal |
Income Yearly
| Metric | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 174,069,000,000USD | 160,401,000,000USD | 153,566,000,000USD | 48,650,000,000USD | 41,806,000,000USD | 37,876,000,000USD | 34,914,000,000USD | 32,380,000,000USD |
| Cost Of Revenue | 151,118,000,000USD | 136,194,000,000USD | 128,487,000,000USD | 32,321,000,000USD | 27,719,000,000USD | 25,424,000,000USD | 23,241,000,000USD | 28,382,000,000USD |
| Gross Profit | 22,951,000,000USD | 24,207,000,000USD | 25,079,000,000USD | 16,329,000,000USD | 14,087,000,000USD | 12,452,000,000USD | 11,673,000,000USD | 32,380,000,000USD |
| Selling General Administrative | 12,242,000,000USD | 14,072,000,000USD | 14,053,000,000USD | 11,934,000,000USD | 9,831,000,000USD | 9,750,000,000USD | 8,819,000,000USD | 7,566,000,000USD |
| Unclassified Operating Expenses | 2,768,000,000USD | 1,982,000,000USD | 2,949,000,000USD | 235,000,000USD | 314,000,000USD | -9,658,000,000USD | -8,734,000,000USD | 15,072,000,000USD |
| Total Operating Expenses | 15,010,000,000USD | 16,054,000,000USD | 17,002,000,000USD | 12,169,000,000USD | 10,145,000,000USD | 92,000,000USD | 85,000,000USD | 30,204,000,000USD |
| Operating Income | 7,941,000,000USD | 8,153,000,000USD | 8,077,000,000USD | 4,160,000,000USD | 3,942,000,000USD | 12,360,000,000USD | 11,588,000,000USD | 32,380,000,000USD |
| Interest Income | 1,208,000,000USD | 1,438,000,000USD | 1,682,000,000USD | 271,000,000USD | 252,000,000USD | — | — | — |
| Interest Expense | 1,208,000,000USD | 1,438,000,000USD | 1,682,000,000USD | 498,000,000USD | 252,000,000USD | 0USD | 0USD | 264,000,000USD |
| Net Interest Income | -1,208,000,000USD | -1,438,000,000USD | -1,682,000,000USD | -498,000,000USD | -252,000,000USD | — | — | — |
| Income Before Tax | 6,790,000,000USD | 10,868,000,000USD | 6,570,000,000USD | 3,581,000,000USD | 3,606,000,000USD | 3,327,000,000USD | 3,304,000,000USD | 2,176,000,000USD |
| Income Tax Expense | 1,370,000,000USD | 2,379,000,000USD | 1,450,000,000USD | 935,000,000USD | 1,374,000,000USD | 1,250,000,000USD | 1,210,000,000USD | 698,000,000USD |
| Tax Provision | 1,367,000,000USD | 2,379,000,000USD | 1,450,000,000USD | 939,000,000USD | 1,142,000,000USD | 1,250,000,000USD | — | — |
| Net Income | 5,370,000,000USD | 8,458,000,000USD | 5,104,000,000USD | 2,637,000,000USD | 2,237,000,000USD | 2,094,000,000USD | 2,102,000,000USD | 1,476,000,000USD |
| Net Income From Continuing Ops | 5,415,000,000USD | 8,489,000,000USD | 5,120,000,000USD | 2,646,000,000USD | 2,232,000,000USD | 2,077,000,000USD | 2,094,000,000USD | — |
| Ebit | 8,162,000,000USD | 8,565,000,000USD | 8,815,000,000USD | 4,864,000,000USD | 4,126,000,000USD | 3,493,000,000USD | 3,304,000,000USD | 0USD |
| Ebitda | 9,963,000,000USD | 10,368,000,000USD | 11,582,000,000USD | 5,220,000,000USD | 4,376,000,000USD | 3,795,000,000USD | 3,620,000,000USD | 597,000,000USD |
| Depreciation And Amortization | 1,801,000,000USD | 1,803,000,000USD | 2,767,000,000USD | 356,000,000USD | 250,000,000USD | 302,000,000USD | 316,000,000USD | 597,000,000USD |
| Reconciled Depreciation | 2,923,000,000USD | 2,802,000,000USD | 3,651,000,000USD | 695,000,000USD | 566,000,000USD | — | — | — |
| Total Other Income Expense Net | -1,151,000,000USD | 2,715,000,000USD | -1,507,000,000USD | -579,000,000USD | -336,000,000USD | -9,033,000,000USD | -8,284,000,000USD | -30,204,000,000USD |
| Non Operating Income Net Other | -1,349,000,000USD | 2,566,000,000USD | -1,684,000,000USD | -498,000,000USD | — | — | — | — |
| Minority Interest | 50,000,000USD | 31,000,000USD | 41,000,000USD | 44,000,000USD | 49,000,000USD | 78,000,000USD | 105,000,000USD | 2,000,000USD |
| Net Income Applicable To Common Shares | 5,365,000,000USD | 8,458,000,000USD | 5,104,000,000USD | 2,637,000,000USD | 2,237,000,000USD | 2,094,000,000USD | 2,102,000,000USD | 1,476,000,000USD |
| Research Development | — | — | — | 0USD | 0USD | 0USD | 0USD | 0USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 7,566,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 157,082,000,000USD | 153,266,000,000USD | 157,919,000,000USD | 157,919,000,000USD | 151,651,000,000USD | 150,658,000,000USD | 155,881,000,000USD | 157,639,000,000USD |
| Cash And Equivalents | 6,298,000,000USD | — | 7,676,000,000USD | 6,025,000,000USD | 4,329,000,000USD | 8,334,000,000USD | 7,550,000,000USD | 5,888,000,000USD |
| Cash And Short Term Investments | 7,257,000,000USD | 7,852,000,000USD | 7,676,000,000USD | 6,908,000,000USD | 5,142,000,000USD | 9,061,000,000USD | 8,215,000,000USD | 6,752,000,000USD |
| Short Term Investments | 959,000,000USD | 812,000,000USD | 970,000,000USD | 883,000,000USD | 813,000,000USD | 727,000,000USD | 665,000,000USD | 864,000,000USD |
| Long Term Investments | 19,037,000,000USD | 12,260,000,000USD | 12,175,000,000USD | 12,144,000,000USD | 813,000,000USD | 727,000,000USD | 665,000,000USD | 864,000,000USD |
| Total Current Assets | 46,991,000,000USD | 43,032,000,000USD | 47,814,000,000USD | 46,735,000,000USD | 44,723,000,000USD | 43,555,000,000USD | 48,870,000,000USD | 49,222,000,000USD |
| Other Current Assets | 3,087,000,000USD | 2,742,000,000USD | 4,032,000,000USD | 2,486,000,000USD | 2,466,000,000USD | 3,080,000,000USD | 9,898,000,000USD | 9,541,000,000USD |
| Other Non Current Assets | 3,323,000,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 114,172,000,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 55,562,000,000USD | 52,606,000,000USD | 56,342,000,000USD | 56,453,000,000USD | 56,779,000,000USD | 55,745,000,000USD | 57,979,000,000USD | 57,060,000,000USD |
| Other Non Current Liabilities | 5,612,000,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 42,620,000,000USD | 42,210,000,000USD | 41,713,000,000USD | 41,805,000,000USD | 40,214,000,000USD | 40,226,000,000USD | 41,033,000,000USD | 42,095,000,000USD |
| Total Equity Including Noncontrolling Interest | 42,910,000,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 29,086,000,000USD | 29,371,000,000USD | 30,871,000,000USD | 30,947,000,000USD | 26,480,000,000USD | 26,455,000,000USD | 28,937,000,000USD | 30,230,000,000USD |
| Net Receivables | 30,800,000,000USD | 26,607,000,000USD | 28,768,000,000USD | 31,709,000,000USD | 31,148,000,000USD | 26,238,000,000USD | 24,065,000,000USD | 27,846,000,000USD |
| Inventory | 5,847,000,000USD | 5,831,000,000USD | 7,338,000,000USD | 5,632,000,000USD | 5,967,000,000USD | 5,176,000,000USD | 6,692,000,000USD | 5,083,000,000USD |
| Property Plant Equipment Net | 3,736,000,000USD | 3,704,000,000USD | 3,651,000,000USD | 3,650,000,000USD | 3,621,000,000USD | 3,681,000,000USD | 828,000,000USD | 3,594,000,000USD |
| Goodwill | 45,534,000,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 26,931,000,000USD | 27,318,000,000USD | 28,560,000,000USD | 28,975,000,000USD | 28,671,000,000USD | 29,045,000,000USD | 32,243,000,000USD | 29,791,000,000USD |
| Accounts Payable | 10,409,000,000USD | 35,642,000,000USD | 40,992,000,000USD | 39,647,000,000USD | 39,398,000,000USD | 37,736,000,000USD | 37,759,000,000USD | 37,316,000,000USD |
| Short Term Debt | 2,792,000,000USD | 1,529,000,000USD | 592,000,000USD | 3,093,000,000USD | 4,288,000,000USD | 3,993,000,000USD | 3,035,000,000USD | 2,572,000,000USD |
| Common Stock | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD |
| Retained Earnings | 50,355,000,000USD | 49,106,000,000USD | 47,865,000,000USD | 47,028,000,000USD | 45,564,000,000USD | 44,434,000,000USD | 43,519,000,000USD | 42,480,000,000USD |
| Accumulated Other Comprehensive Income | -4,361,000,000USD | -3,598,000,000USD | -2,806,000,000USD | -2,799,000,000USD | -2,816,000,000USD | -2,590,000,000USD | -2,341,000,000USD | -2,163,000,000USD |
| Total Liab | — | 110,824,000,000USD | 116,045,000,000USD | 115,905,000,000USD | 111,221,000,000USD | 110,244,000,000USD | 114,638,000,000USD | 115,341,000,000USD |
| Other Current Liab | — | 15,435,000,000USD | 14,758,000,000USD | 13,713,000,000USD | 13,093,000,000USD | 14,016,000,000USD | 17,185,000,000USD | 17,172,000,000USD |
| Capital Stock | — | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD |
| Good Will | — | 45,534,000,000USD | 44,924,000,000USD | 44,924,000,000USD | 44,375,000,000USD | 44,372,000,000USD | 44,370,000,000USD | 44,374,000,000USD |
| Cash | — | 7,040,000,000USD | 7,676,000,000USD | 6,025,000,000USD | 4,329,000,000USD | 8,334,000,000USD | 7,550,000,000USD | 5,888,000,000USD |
| Net Debt | — | 23,860,000,000USD | 23,787,000,000USD | 28,015,000,000USD | 26,439,000,000USD | 22,114,000,000USD | 24,422,000,000USD | 26,914,000,000USD |
| Short Long Term Debt | — | 1,529,000,000USD | 592,000,000USD | 3,093,000,000USD | 4,288,000,000USD | 3,993,000,000USD | 3,035,000,000USD | 2,572,000,000USD |
| Short Long Term Debt Total | — | 30,900,000,000USD | 31,463,000,000USD | 34,040,000,000USD | 30,768,000,000USD | 30,448,000,000USD | 31,972,000,000USD | 32,802,000,000USD |
| Common Stock Shares Outstanding | — | 264,217,252shares | 265,948,276shares | 268,154,000shares | 268,154,000shares | 283,218,000shares | 277,784,000shares | 281,396,000shares |
| Non Current Assets Total | — | 110,234,000,000USD | 110,105,000,000USD | 111,184,000,000USD | 106,928,000,000USD | 107,103,000,000USD | 107,011,000,000USD | 108,417,000,000USD |
| Non Current Liabilities Total | — | 58,218,000,000USD | 59,703,000,000USD | 59,452,000,000USD | 54,442,000,000USD | 54,499,000,000USD | 56,659,000,000USD | 58,281,000,000USD |
| Non Current Liabilities Other | — | 12,219,000,000USD | 11,749,000,000USD | 11,429,000,000USD | 11,024,000,000USD | 10,856,000,000USD | — | — |
| Non Currrent Assets Other | — | 14,776,000,000USD | 14,499,000,000USD | 15,152,000,000USD | 14,599,000,000USD | 14,655,000,000USD | 14,442,000,000USD | 15,388,000,000USD |
| Net Working Capital | — | -9,574,000,000USD | -8,528,000,000USD | -9,718,000,000USD | -12,056,000,000USD | -12,190,000,000USD | — | — |
| Unclassified Non Current Assets | — | 6,642,000,000USD | -8,203,000,000USD | -8,813,000,000USD | -132,505,000,000USD | — | -141,418,000,000USD | 14,406,000,000USD |
| Unclassified Current Liabilities | — | -1,529,000,000USD | -592,000,000USD | -3,093,000,000USD | -4,288,000,000USD | -3,993,000,000USD | -3,035,000,000USD | -2,572,000,000USD |
| Unclassified Non Current Liabilities | — | 16,628,000,000USD | 17,083,000,000USD | 17,076,000,000USD | 16,938,000,000USD | 17,188,000,000USD | 27,722,000,000USD | 28,051,000,000USD |
| Unclassified Equity | — | -3,306,000,000USD | -3,354,000,000USD | -2,432,000,000USD | -2,542,000,000USD | -1,626,000,000USD | — | 1,770,000,000USD |
| Other Assets | — | — | 14,499,000,000USD | 15,152,000,000USD | 147,354,000,000USD | 14,655,000,000USD | 155,881,000,000USD | -4,557,000,000USD |
| Property Plant Equipment Gross | — | — | 13,753,000,000USD | — | — | — | — | — |
| Unclassified Current Assets | — | — | -970,000,000USD | — | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 157,919,000,000USD | 155,881,000,000USD | 152,761,000,000USD | 143,885,000,000USD | 154,889,000,000USD | 155,451,000,000USD | 155,774,000,000USD | 153,226,000,000USD |
| Intangible Assets | 28,560,000,000USD | 32,243,000,000USD | 33,681,000,000USD | 35,340,000,000USD | 36,911,000,000USD | 38,192,000,000USD | 39,763,000,000USD | 42,282,000,000USD |
| Other Current Assets | 4,032,000,000USD | 9,898,000,000USD | 5,509,000,000USD | 1,546,000,000USD | 11,796,000,000USD | 1,122,000,000USD | 11,246,000,000USD | 1,512,000,000USD |
| Total Liab | 116,045,000,000USD | 114,638,000,000USD | 106,410,000,000USD | 98,981,000,000USD | 107,705,000,000USD | 105,065,000,000USD | 110,395,000,000USD | 112,154,000,000USD |
| Total Stockholder Equity | 41,713,000,000USD | 41,033,000,000USD | 46,223,000,000USD | 44,872,000,000USD | 47,112,000,000USD | 50,321,000,000USD | 45,338,000,000USD | 41,028,000,000USD |
| Other Current Liab | 45,091,000,000USD | 17,185,000,000USD | 17,573,000,000USD | 13,273,000,000USD | 18,904,000,000USD | 13,671,000,000USD | 18,914,000,000USD | 13,872,000,000USD |
| Common Stock | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD |
| Capital Stock | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD | 4,000,000USD |
| Retained Earnings | 47,865,000,000USD | 43,519,000,000USD | 41,652,000,000USD | 37,874,000,000USD | 32,593,000,000USD | 28,575,000,000USD | 20,162,000,000USD | 15,088,000,000USD |
| Good Will | 44,924,000,000USD | 44,370,000,000USD | 44,259,000,000USD | 45,811,000,000USD | 45,811,000,000USD | 44,648,000,000USD | 44,602,000,000USD | 44,505,000,000USD |
| Other Assets | 14,499,000,000USD | 14,442,000,000USD | 4,835,000,000USD | 32,160,000,000USD | 43,965,000,000USD | 41,184,000,000USD | 47,884,000,000USD | 65,156,000,000USD |
| Cash | 7,676,000,000USD | 7,550,000,000USD | 7,822,000,000USD | 5,924,000,000USD | 5,081,000,000USD | 10,182,000,000USD | 4,619,000,000USD | 3,855,000,000USD |
| Cash And Equivalents | 7,676,000,000USD | 7,550,000,000USD | 7,822,000,000USD | 5,924,000,000USD | 5,081,000,000USD | 10,182,000,000USD | 4,619,000,000USD | 3,855,000,000USD |
| Cash And Short Term Investments | 7,676,000,000USD | 8,215,000,000USD | 8,747,000,000USD | 6,829,000,000USD | 6,001,000,000USD | 11,513,000,000USD | 5,556,000,000USD | 5,900,000,000USD |
| Total Current Assets | 47,814,000,000USD | 48,870,000,000USD | 37,351,000,000USD | 30,122,000,000USD | 36,134,000,000USD | 27,799,000,000USD | 29,845,000,000USD | 20,430,000,000USD |
| Total Current Liabilities | 56,342,000,000USD | 57,979,000,000USD | 48,716,000,000USD | 41,225,000,000USD | 43,572,000,000USD | 36,022,000,000USD | 40,138,000,000USD | 31,895,000,000USD |
| Net Debt | 23,787,000,000USD | 24,422,000,000USD | 23,108,000,000USD | 25,629,000,000USD | 29,184,000,000USD | 23,380,000,000USD | 33,419,000,000USD | 38,623,000,000USD |
| Short Term Debt | 592,000,000USD | 3,035,000,000USD | 2,775,000,000USD | 3,107,000,000USD | 2,704,000,000USD | 3,526,000,000USD | 5,680,000,000USD | 2,955,000,000USD |
| Short Long Term Debt | 592,000,000USD | 3,035,000,000USD | 2,775,000,000USD | 2,993,000,000USD | 2,545,000,000USD | 3,374,000,000USD | 5,514,000,000USD | 2,955,000,000USD |
| Short Long Term Debt Total | 31,463,000,000USD | 31,972,000,000USD | 30,930,000,000USD | 31,553,000,000USD | 34,265,000,000USD | 33,562,000,000USD | 38,038,000,000USD | 42,478,000,000USD |
| Long Term Debt | 30,871,000,000USD | 28,937,000,000USD | 28,155,000,000USD | 28,034,000,000USD | 31,097,000,000USD | 29,545,000,000USD | 31,832,000,000USD | 39,523,000,000USD |
| Long Term Investments | 12,175,000,000USD | 665,000,000USD | 925,000,000USD | 16,288,000,000USD | 18,438,000,000USD | 23,262,000,000USD | 937,000,000USD | 2,045,000,000USD |
| Short Term Investments | 970,000,000USD | 665,000,000USD | 925,000,000USD | 905,000,000USD | 920,000,000USD | 1,331,000,000USD | 937,000,000USD | 2,045,000,000USD |
| Net Receivables | 28,768,000,000USD | 24,065,000,000USD | 17,450,000,000USD | 16,970,000,000USD | 14,615,000,000USD | 11,999,000,000USD | 10,382,000,000USD | 10,197,000,000USD |
| Inventory | 7,338,000,000USD | 6,692,000,000USD | 5,645,000,000USD | 4,777,000,000USD | 3,722,000,000USD | 3,165,000,000USD | 2,661,000,000USD | 2,821,000,000USD |
| Accounts Payable | 10,659,000,000USD | 37,759,000,000USD | 28,368,000,000USD | 24,845,000,000USD | 21,964,000,000USD | 18,825,000,000USD | 15,544,000,000USD | 15,068,000,000USD |
| Property Plant Equipment Net | 3,651,000,000USD | 828,000,000USD | 877,000,000USD | 1,301,000,000USD | 1,664,000,000USD | 1,744,000,000USD | 1,752,000,000USD | 1,283,000,000USD |
| Property Plant Equipment Gross | 13,753,000,000USD | 13,108,000,000USD | 12,261,000,000USD | 11,204,000,000USD | — | 4,205,000,000USD | 4,417,000,000USD | 4,562,000,000USD |
| Accumulated Other Comprehensive Income | -2,806,000,000USD | -2,341,000,000USD | -1,864,000,000USD | -1,395,000,000USD | -884,000,000USD | -861,000,000USD | -941,000,000USD | -1,711,000,000USD |
| Common Stock Shares Outstanding | 265,948,000shares | 283,218,000shares | 296,882,000shares | 313,065,000shares | 340,966,000shares | 368,389,000shares | 379,817,000shares | 246,652,000shares |
| Non Current Assets Total | 110,105,000,000USD | 107,011,000,000USD | 115,410,000,000USD | 113,763,000,000USD | 118,755,000,000USD | 127,652,000,000USD | 125,929,000,000USD | 132,796,000,000USD |
| Non Current Liabilities Total | 59,703,000,000USD | 56,659,000,000USD | 57,694,000,000USD | 57,906,000,000USD | 64,133,000,000USD | 69,043,000,000USD | 70,257,000,000USD | 80,259,000,000USD |
| Non Current Liabilities Other | 11,749,000,000USD | 10,493,000,000USD | 10,871,000,000USD | 21,901,000,000USD | 24,662,000,000USD | 30,559,000,000USD | 28,977,000,000USD | 31,283,000,000USD |
| Non Currrent Assets Other | 14,499,000,000USD | 14,442,000,000USD | 18,608,000,000USD | 15,075,000,000USD | 15,973,000,000USD | 19,869,000,000USD | 18,319,000,000USD | 17,797,000,000USD |
| Net Working Capital | -8,528,000,000USD | -9,109,000,000USD | -11,365,000,000USD | -11,103,000,000USD | — | — | — | — |
| Unclassified Current Assets | -970,000,000USD | — | — | — | — | — | — | — |
| Unclassified Non Current Assets | -8,203,000,000USD | — | 12,225,000,000USD | -32,212,000,000USD | -44,007,000,000USD | -41,247,000,000USD | -27,328,000,000USD | -40,272,000,000USD |
| Unclassified Current Liabilities | -592,000,000USD | -3,035,000,000USD | -2,775,000,000USD | -2,993,000,000USD | -2,545,000,000USD | -3,374,000,000USD | -5,514,000,000USD | -2,955,000,000USD |
| Unclassified Non Current Liabilities | 17,083,000,000USD | 17,229,000,000USD | 18,668,000,000USD | -29,086,000,000USD | -32,980,000,000USD | -39,498,000,000USD | -37,838,000,000USD | -40,736,000,000USD |
| Unclassified Equity | -3,354,000,000USD | — | 6,427,000,000USD | 30,229,000,000USD | 29,570,000,000USD | 28,971,000,000USD | 28,302,000,000USD | 27,747,000,000USD |
| Deferred Long Term Liab | — | — | — | 7,751,000,000USD | 8,346,000,000USD | 8,939,000,000USD | 9,387,000,000USD | 9,453,000,000USD |
| Other Liab | — | — | — | 29,306,000,000USD | 33,008,000,000USD | 39,498,000,000USD | 37,899,000,000USD | 40,736,000,000USD |
| Treasury Stock | — | — | — | -21,844,000,000USD | -14,175,000,000USD | -6,372,000,000USD | -2,193,000,000USD | -104,000,000USD |
| Net Tangible Assets | — | — | — | -33,365,000,000USD | -32,801,000,000USD | -29,448,000,000USD | -35,826,000,000USD | -45,759,000,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | -24,574,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Net Income | 3,736,000,000USD |
| Depreciation | 1,305,000,000USD |
| Deferred Income Tax | -170,000,000USD |
| Other Non Cash Items | -206,000,000USD |
| Unclassified Operating Cash Flow | -429,000,000USD |
| Change To Account Receivables | -2,044,000,000USD |
| Change To Inventory | 1,490,000,000USD |
| Change To Liabilities | -2,972,000,000USD |
| Change In Working Capital | -3,955,000,000USD |
| Operating Cash Flow | 710,000,000USD |
| Capital Expenditures | -564,000,000USD |
| Net Investments | -366,000,000USD |
| Other Investing Activities | -22,000,000USD |
| Unclassified Investing Cash Flow | -188,000,000USD |
| Investing Cash Flow | -1,140,000,000USD |
| Net Debt Issuance | 425,000,000USD |
| Common Stock Issuance | 158,000,000USD |
| Net Common Stock Issuance | -122,000,000USD |
| Common Dividends Paid | -826,000,000USD |
| Other Financing Activities | -327,000,000USD |
| Unclassified Financing Cash Flow | -84,000,000USD |
| Financing Cash Flow | -934,000,000USD |
| Effect Of Forex Changes On Cash | -16,000,000USD |
| Change In Cash | -1,380,000,000USD |
| End Cash Flow | 6,356,000,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,861,000,000USD | 1,868,000,000USD | 1,632,000,000USD | 1,409,000,000USD | 1,536,000,000USD | 825,000,000USD | 1,629,000,000USD | -212,000,000USD |
| Depreciation | 650,000,000USD | 697,000,000USD | 682,000,000USD | 674,000,000USD | 646,000,000USD | 650,000,000USD | 738,000,000USD | 741,000,000USD |
| Other Non Cash Items | 43,000,000USD | -76,000,000USD | -52,000,000USD | -39,000,000USD | -198,000,000USD | 1,008,000,000USD | 48,000,000USD | 1,855,000,000USD |
| Change To Account Receivables | 2,152,000,000USD | -111,000,000USD | -4,376,000,000USD | -2,424,000,000USD | 3,104,000,000USD | -3,086,000,000USD | -5,253,000,000USD | -2,619,000,000USD |
| Change To Inventory | 1,507,000,000USD | 1,060,000,000USD | 726,000,000USD | 1,517,000,000USD | — | 105,000,000USD | -543,000,000USD | 1,015,000,000USD |
| Change In Working Capital | -1,363,000,000USD | 811,000,000USD | -4,072,000,000USD | 92,000,000USD | 2,972,000,000USD | -2,285,000,000USD | -2,053,000,000USD | 2,558,000,000USD |
| Total Cash From Operating Activities | 1,131,000,000USD | 3,418,000,000USD | -1,886,000,000USD | 1,920,000,000USD | 5,212,000,000USD | 46,000,000USD | 265,000,000USD | 4,840,000,000USD |
| Capital Expenditures | -267,000,000USD | -278,000,000USD | -285,000,000USD | -327,000,000USD | -337,000,000USD | -399,000,000USD | -370,000,000USD | -300,000,000USD |
| Free Cash Flow | 864,000,000USD | 3,140,000,000USD | -2,171,000,000USD | 1,593,000,000USD | 4,875,000,000USD | -353,000,000USD | -105,000,000USD | 4,540,000,000USD |
| Investments | -254,000,000USD | -4,387,000,000USD | -797,000,000USD | 1,197,000,000USD | -191,000,000USD | -776,000,000USD | -640,000,000USD | -495,000,000USD |
| Total Cashflows From Investing Activities | -637,000,000USD | -4,387,000,000USD | -797,000,000USD | 1,197,000,000USD | -191,000,000USD | -776,000,000USD | -640,000,000USD | -495,000,000USD |
| Net Borrowings | -563,000,000USD | 3,206,000,000USD | 287,000,000USD | -1,591,000,000USD | -768,000,000USD | 833,000,000USD | — | — |
| Total Cash From Financing Activities | -1,141,000,000USD | 2,659,000,000USD | -1,333,000,000USD | -3,681,000,000USD | -3,248,000,000USD | 439,000,000USD | -2,309,000,000USD | -2,529,000,000USD |
| Dividends Paid | -417,000,000USD | -402,000,000USD | -401,000,000USD | -412,000,000USD | -384,000,000USD | -390,000,000USD | -392,000,000USD | -401,000,000USD |
| Sale Purchase Of Stock | 0USD | -2,442,000,000USD | -1,112,000,000USD | -1,508,000,000USD | -2,022,000,000USD | -4,729,000,000USD | -990,000,000USD | -4,022,000,000USD |
| Issuance Of Capital Stock | 57,000,000USD | 37,000,000USD | 72,000,000USD | 69,000,000USD | 22,000,000USD | 62,000,000USD | 40,000,000USD | 181,000,000USD |
| Change In Cash | -656,000,000USD | 1,696,000,000USD | -3,990,000,000USD | -555,000,000USD | 1,747,000,000USD | -273,000,000USD | -2,687,000,000USD | 1,807,000,000USD |
| Begin Period Cash Flow | 7,736,000,000USD | 4,329,000,000USD | 8,376,000,000USD | 8,931,000,000USD | 7,184,000,000USD | 7,457,000,000USD | 10,144,000,000USD | 8,337,000,000USD |
| End Period Cash Flow | 7,080,000,000USD | 6,025,000,000USD | 4,386,000,000USD | 8,376,000,000USD | 8,931,000,000USD | 7,184,000,000USD | 7,457,000,000USD | 10,144,000,000USD |
| Other Cashflows From Investing Activities | -136,000,000USD | -2,839,000,000USD | -275,000,000USD | -42,000,000USD | -378,000,000USD | -95,000,000USD | -225,000,000USD | -140,000,000USD |
| Other Cashflows From Financing Activities | -218,000,000USD | -183,000,000USD | -179,000,000USD | -239,000,000USD | -96,000,000USD | -66,000,000USD | -74,000,000USD | -175,000,000USD |
| Unclassified Operating Cash Flow | -60,000,000USD | 118,000,000USD | -76,000,000USD | -216,000,000USD | — | -152,000,000USD | -97,000,000USD | -102,000,000USD |
| Unclassified Investing Cash Flow | 20,000,000USD | 3,117,000,000USD | 560,000,000USD | 369,000,000USD | 715,000,000USD | 494,000,000USD | 595,000,000USD | 440,000,000USD |
| Unclassified Financing Cash Flow | 57,000,000USD | 2,480,000,000USD | 72,000,000USD | 69,000,000USD | — | 4,791,000,000USD | -853,000,000USD | 2,069,000,000USD |
| Stock Based Compensation | — | — | — | — | 308,000,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 6,288,000,000USD | 3,778,000,000USD | 5,372,000,000USD | 6,782,000,000USD | 5,420,000,000USD | 8,489,000,000USD | 5,120,000,000USD | 2,646,000,000USD |
| Depreciation | 2,775,000,000USD | 2,775,000,000USD | 3,035,000,000USD | 2,937,000,000USD | 2,923,000,000USD | 2,802,000,000USD | 3,651,000,000USD | 695,000,000USD |
| Other Non Cash Items | 473,000,000USD | 2,713,000,000USD | 1,577,000,000USD | -1,175,000,000USD | -57,000,000USD | -4,153,000,000USD | -175,000,000USD | 81,000,000USD |
| Change To Account Receivables | -4,630,000,000USD | -7,854,000,000USD | -2,202,000,000USD | -1,844,000,000USD | -3,498,000,000USD | -1,573,000,000USD | -990,000,000USD | 471,000,000USD |
| Change To Inventory | -646,000,000USD | -1,032,000,000USD | -868,000,000USD | -1,055,000,000USD | 143,000,000USD | 30,000,000USD | 149,000,000USD | 216,000,000USD |
| Change In Working Capital | -261,000,000USD | 1,192,000,000USD | 3,488,000,000USD | 584,000,000USD | -879,000,000USD | 3,598,000,000USD | 1,202,000,000USD | 449,000,000USD |
| Total Cash From Operating Activities | 9,601,000,000USD | 10,363,000,000USD | 11,813,000,000USD | 8,656,000,000USD | 7,191,000,000USD | 10,350,000,000USD | 9,485,000,000USD | 3,770,000,000USD |
| Capital Expenditures | -1,212,000,000USD | -1,406,000,000USD | -1,573,000,000USD | -1,295,000,000USD | -1,154,000,000USD | -1,094,000,000USD | -1,050,000,000USD | -528,000,000USD |
| Free Cash Flow | 8,389,000,000USD | 8,957,000,000USD | 10,240,000,000USD | 7,361,000,000USD | 6,037,000,000USD | 9,256,000,000USD | 8,435,000,000USD | 3,242,000,000USD |
| Investments | -4,552,000,000USD | -2,102,000,000USD | -5,174,000,000USD | -587,000,000USD | -765,000,000USD | -443,000,000USD | -4,832,000,000USD | -1,383,000,000USD |
| Total Cashflows From Investing Activities | -4,407,000,000USD | -2,102,000,000USD | -5,174,000,000USD | 3,098,000,000USD | -3,611,000,000USD | 2,976,000,000USD | -734,000,000USD | -26,378,000,000USD |
| Net Borrowings | -667,000,000USD | 1,060,000,000USD | -278,000,000USD | -500,000,000USD | 800,000,000USD | -4,796,000,000USD | -5,175,000,000USD | 24,212,000,000USD |
| Total Cash From Financing Activities | -6,421,000,000USD | -7,647,000,000USD | -4,294,000,000USD | -11,240,000,000USD | -8,212,000,000USD | -8,533,000,000USD | -7,187,000,000USD | 23,515,000,000USD |
| Dividends Paid | -1,611,000,000USD | -1,567,000,000USD | -1,450,000,000USD | -1,384,000,000USD | -1,341,000,000USD | -15,000,000USD | -15,000,000USD | -24,343,000,000USD |
| Sale Purchase Of Stock | -3,621,000,000USD | -7,034,000,000USD | -2,284,000,000USD | -7,607,000,000USD | -7,742,000,000USD | -4,042,000,000USD | -1,987,000,000USD | -342,000,000USD |
| Issuance Of Capital Stock | 203,000,000USD | 305,000,000USD | 185,000,000USD | 389,000,000USD | 326,000,000USD | 376,000,000USD | 224,000,000USD | 68,000,000USD |
| Change In Cash | 126,000,000USD | 594,000,000USD | 2,361,000,000USD | 428,000,000USD | -4,697,000,000USD | 4,834,000,000USD | 1,556,000,000USD | 883,000,000USD |
| Begin Period Cash Flow | 7,550,000,000USD | 8,337,000,000USD | 5,976,000,000USD | 5,548,000,000USD | 10,245,000,000USD | 5,411,000,000USD | 3,855,000,000USD | 2,972,000,000USD |
| End Period Cash Flow | 7,676,000,000USD | 8,931,000,000USD | 8,337,000,000USD | 5,976,000,000USD | 5,548,000,000USD | 10,245,000,000USD | 5,411,000,000USD | 3,855,000,000USD |
| Other Cashflows From Investing Activities | -1,030,000,000USD | -838,000,000USD | -264,000,000USD | -233,000,000USD | -50,000,000USD | -71,000,000USD | -119,000,000USD | -109,000,000USD |
| Other Cashflows From Financing Activities | -726,000,000USD | -411,000,000USD | -469,000,000USD | -79,000,000USD | -112,000,000USD | -328,000,000USD | -237,000,000USD | -423,000,000USD |
| Unclassified Operating Cash Flow | 326,000,000USD | -403,000,000USD | -1,945,000,000USD | -736,000,000USD | -484,000,000USD | -675,000,000USD | -612,000,000USD | -281,000,000USD |
| Unclassified Investing Cash Flow | 2,387,000,000USD | 2,244,000,000USD | 1,837,000,000USD | 5,213,000,000USD | -1,642,000,000USD | 4,584,000,000USD | 5,267,000,000USD | -24,358,000,000USD |
| Unclassified Financing Cash Flow | 204,000,000USD | 305,000,000USD | 187,000,000USD | -1,670,000,000USD | 183,000,000USD | 648,000,000USD | 227,000,000USD | 24,411,000,000USD |
| Stock Based Compensation | — | 308,000,000USD | 286,000,000USD | 264,000,000USD | 268,000,000USD | 289,000,000USD | 299,000,000USD | 180,000,000USD |
| Change To Liabilities | — | — | — | 1,865,000,000USD | -77,000,000USD | 2,187,000,000USD | 1,918,000,000USD | 892,000,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 514,000,000USD | -4,632,000,000USD | 4,793,000,000USD | 1,564,000,000USD | 883,000,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | -24,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
Adjusted Income from Operations
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 2,054,000,000 | USD | Disclosure |
Cigna Healthcare Medical Care Ratio
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 84.5 | percent | Disclosure |
Cigna Healthcare SG&A Expense Ratio
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 19.6 | percent | Disclosure |
Evernorth Health Services SG&A Expense Ratio
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 1.7 | percent | Disclosure |
International Health Administrative-Services-Only Medical Customers
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 473 | thousand customers | Disclosure |
International Health Insured Medical Customers
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 1,262 | thousand customers | Disclosure |
Pharmacy Claim Volume
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 537 | million adjusted claims | Disclosure |
Total Administrative-Services-Only Medical Customers
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 14,712 | thousand customers | Disclosure |
Total Cigna Healthcare Medical Customers
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 18,413 | thousand customers | Disclosure |
Total Insured Medical Customers
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 3,701 | thousand customers | Disclosure |
U.S. Healthcare Administrative-Services-Only Medical Customers
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 14,239 | thousand customers | Disclosure |
U.S. Healthcare Insured Medical Customers
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 2,439 | thousand customers | Disclosure |
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Product | 57,172,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Service Fees And Other Revenues | 9,816,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Service Other | 315,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Services | 4,365,000,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 54,037,000,000 | USD | 0001739940-26-000043 |
| Q1 2026Quarterly · 2026-03-31 | Product | Service Fees And Other Revenues | 9,855,000,000 | USD | 0001739940-26-000043 |
| Q1 2026Quarterly · 2026-03-31 | Product | Service Other | 159,000,000 | USD | 0001739940-26-000043 |
| Q1 2026Quarterly · 2026-03-31 | Product | Services | 4,443,000,000 | USD | 0001739940-26-000043 |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 58,336,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Service Fees And Other Revenues | 9,483,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Service Other | 144,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Services | 4,509,000,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Product | 216,672,000,000 | USD | 0001739940-26-000006 |
| FY 2025Yearly · 2025-12-31 | Product | Service Fees And Other Revenues | 40,611,000,000 | USD | 0001739940-26-000006 |
| FY 2025Yearly · 2025-12-31 | Product | Service Other | 696,000,000 | USD | 0001739940-26-000006 |
| FY 2025Yearly · 2025-12-31 | Product | Services | 16,921,000,000 | USD | 0001739940-26-000006 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 56,054,000,000 | USD | 0001739940-25-000037 |
| Q3 2025Quarterly · 2025-09-30 | Product | Service Fees And Other Revenues | 9,038,000,000 | USD | 0001739940-25-000037 |
| Q3 2025Quarterly · 2025-09-30 | Product | Service Other | 276,000,000 | USD | 0001739940-25-000037 |
| Q3 2025Quarterly · 2025-09-30 | Product | Services | 4,380,000,000 | USD | 0001739940-25-000037 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 53,649,000,000 | USD | 0001739940-25-000028 |
| Q2 2025Quarterly · 2025-06-30 | Product | Service Fees And Other Revenues | 9,278,000,000 | USD | 0001739940-25-000028 |
| Q2 2025Quarterly · 2025-06-30 | Product | Service Other | 114,000,000 | USD | 0001739940-25-000028 |
| Q2 2025Quarterly · 2025-06-30 | Product | Services | 4,137,000,000 | USD | 0001739940-25-000028 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 48,633,000,000 | USD | 0001739940-26-000043 |
| Q1 2025Quarterly · 2025-03-31 | Product | Service Fees And Other Revenues | 12,812,000,000 | USD | 0001739940-26-000043 |
| Q1 2025Quarterly · 2025-03-31 | Product | Service Other | 162,000,000 | USD | 0001739940-26-000043 |
| Q1 2025Quarterly · 2025-03-31 | Product | Services | 3,895,000,000 | USD | 0001739940-26-000043 |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 49,941,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Service Fees And Other Revenues | 11,705,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Service Other | 75,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Services | 3,928,000,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Product | 185,362,000,000 | USD | 0001739940-26-000006 |
| FY 2024Yearly · 2024-12-31 | Product | Service Fees And Other Revenues | 46,385,000,000 | USD | 0001739940-26-000006 |
| FY 2024Yearly · 2024-12-31 | Product | Service Other | 584,000,000 | USD | 0001739940-26-000006 |
| FY 2024Yearly · 2024-12-31 | Product | Services | 14,790,000,000 | USD | 0001739940-26-000006 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 48,284,000,000 | USD | 0001739940-25-000037 |
| Q3 2024Quarterly · 2024-09-30 | Product | Service Fees And Other Revenues | 11,254,000,000 | USD | 0001739940-25-000037 |
| Q3 2024Quarterly · 2024-09-30 | Product | Service Other | 267,000,000 | USD | 0001739940-25-000037 |
| Q3 2024Quarterly · 2024-09-30 | Product | Services | 3,889,000,000 | USD | 0001739940-25-000037 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 137,243,000,000 | USD | 0001739940-26-000006 |
| FY 2023Yearly · 2023-12-31 | Product | Service Fees And Other Revenues | 45,193,000,000 | USD | 0001739940-26-000006 |
| FY 2023Yearly · 2023-12-31 | Product | Service Other | 210,000,000 | USD | 0001739940-26-000006 |
| FY 2023Yearly · 2023-12-31 | Product | Services | 12,619,000,000 | USD | 0001739940-26-000006 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 128,566,000,000 | USD | 0001739940-25-000009 |
| FY 2022Yearly · 2022-12-31 | Product | Service Fees And Other Revenues | 40,903,000,000 | USD | 0001739940-25-000009 |
| FY 2022Yearly · 2022-12-31 | Product | Service Other | 168,000,000 | USD | 0001739940-25-000009 |
| FY 2022Yearly · 2022-12-31 | Product | Services | 10,881,000,000 | USD | 0001739940-25-000009 |
| Q3 2021Quarterly · 2021-09-30 | Segment | Evernorth | 33,614,000,000 | USD | 0001739940-21-000024 |
| Q3 2021Quarterly · 2021-09-30 | Segment | Group Disability And Other | 140,000,000 | USD | 0001739940-21-000024 |
| Q3 2021Quarterly · 2021-09-30 | Segment | USMedical | 10,497,000,000 | USD | 0001739940-21-000024 |
| Q2 2021Quarterly · 2021-06-30 | Segment | Evernorth | 32,592,000,000 | USD | 0001739940-21-000017 |
| Q2 2021Quarterly · 2021-06-30 | Segment | Group Disability And Other | 129,000,000 | USD | 0001739940-21-000017 |
| Q2 2021Quarterly · 2021-06-30 | Segment | USMedical | 10,456,000,000 | USD | 0001739940-21-000017 |
| Q1 2021Quarterly · 2021-03-31 | Segment | Evernorth | 30,620,000,000 | USD | 0001739940-21-000011 |
| Q1 2021Quarterly · 2021-03-31 | Segment | Group Disability And Other | 139,000,000 | USD | 0001739940-21-000011 |
| Q1 2021Quarterly · 2021-03-31 | Segment | USMedical | 10,362,000,000 | USD | 0001739940-21-000011 |
| Q4 2020Quarterly · 2020-12-31 | Segment | Evernorth | 30,533,000,000 | USD | Legacy provider |
| Q4 2020Quarterly · 2020-12-31 | Segment | Group Disability And Other | 1,469,000,000 | USD | Legacy provider |
| Q4 2020Quarterly · 2020-12-31 | Segment | USMedical | 9,725,000,000 | USD | Legacy provider |
| FY 2020Yearly · 2020-12-31 | Segment | Evernorth | 116,334,000,000 | USD | 0001739940-21-000007 |
| FY 2020Yearly · 2020-12-31 | Segment | Group Disability And Other | 5,616,000,000 | USD | 0001739940-21-000007 |
| FY 2020Yearly · 2020-12-31 | Segment | USMedical | 38,451,000,000 | USD | 0001739940-21-000007 |
| Q3 2020Quarterly · 2020-09-30 | Segment | Evernorth | 29,944,000,000 | USD | 0001739940-21-000024 |
| Q3 2020Quarterly · 2020-09-30 | Segment | Group Disability And Other | 1,382,000,000 | USD | 0001739940-21-000024 |
| Q3 2020Quarterly · 2020-09-30 | Segment | USMedical | 9,629,000,000 | USD | 0001739940-21-000024 |
| Q2 2020Quarterly · 2020-06-30 | Segment | Evernorth | 28,602,000,000 | USD | 0001739940-21-000017 |
| Q2 2020Quarterly · 2020-06-30 | Segment | Group Disability And Other | 1,426,000,000 | USD | 0001739940-21-000017 |
| Q2 2020Quarterly · 2020-06-30 | Segment | USMedical | 9,237,000,000 | USD | 0001739940-21-000017 |
| Q1 2020Quarterly · 2020-03-31 | Segment | Evernorth | 27,255,000,000 | USD | 0001739940-21-000011 |
| Q1 2020Quarterly · 2020-03-31 | Segment | Group Disability And Other | 1,339,000,000 | USD | 0001739940-21-000011 |
| Q1 2020Quarterly · 2020-03-31 | Segment | USMedical | 9,860,000,000 | USD | 0001739940-21-000011 |
| Q4 2019Quarterly · 2019-12-31 | Segment | Group Disability And Other | 1,777,000,000 | USD | Legacy provider |
| Q4 2019Quarterly · 2019-12-31 | Segment | Health Services | 27,260,000,000 | USD | Legacy provider |
| Q4 2019Quarterly · 2019-12-31 | Segment | Integrated Medical | 9,208,000,000 | USD | Legacy provider |
| FY 2019Yearly · 2019-12-31 | Segment | Evernorth | 109,794,000,000 | USD | 0001739940-21-000007 |
| FY 2019Yearly · 2019-12-31 | Segment | Group Disability And Other | 7,253,000,000 | USD | 0001739940-21-000007 |
| FY 2019Yearly · 2019-12-31 | Segment | USMedical | 36,519,000,000 | USD | 0001739940-21-000007 |
| FY 2018Yearly · 2018-12-31 | Segment | Evernorth | 7,065,000,000 | USD | 0001739940-21-000007 |
| FY 2018Yearly · 2018-12-31 | Segment | Group Disability And Other | 8,794,000,000 | USD | 0001739940-21-000007 |
| FY 2018Yearly · 2018-12-31 | Segment | USMedical | 32,791,000,000 | USD | 0001739940-21-000007 |
| FY 2017Yearly · 2017-12-31 | Segment | All Other Segments | 463,000,000 | USD | 0001047469-18-001158 |
| FY 2017Yearly · 2017-12-31 | Segment | Global Health Benefits | 32,753,000,000 | USD | 0001047469-18-001158 |
| FY 2017Yearly · 2017-12-31 | Segment | Global Supplemental Benefits | 3,904,000,000 | USD | 0001047469-18-001158 |
| FY 2017Yearly · 2017-12-31 | Segment | Group Disability And Life | 4,515,000,000 | USD | 0001047469-18-001158 |
| FY 2016Yearly · 2016-12-31 | Segment | All Other Segments | 467,000,000 | USD | 0001047469-18-001158 |
| FY 2016Yearly · 2016-12-31 | Segment | Global Health Benefits | 31,318,000,000 | USD | 0001047469-18-001158 |
| FY 2016Yearly · 2016-12-31 | Segment | Global Supplemental Benefits | 3,380,000,000 | USD | 0001047469-18-001158 |
| FY 2016Yearly · 2016-12-31 | Segment | Group Disability And Life | 4,502,000,000 | USD | 0001047469-18-001158 |
| FY 2015Yearly · 2015-12-31 | Segment | All Other Segments | 494,000,000 | USD | 0001047469-18-001158 |
| FY 2015Yearly · 2015-12-31 | Segment | Global Health Benefits | 29,972,000,000 | USD | 0001047469-18-001158 |
| FY 2015Yearly · 2015-12-31 | Segment | Global Supplemental Benefits | 3,149,000,000 | USD | 0001047469-18-001158 |
| FY 2015Yearly · 2015-12-31 | Segment | Group Disability And Life | 4,276,000,000 | USD | 0001047469-18-001158 |
| FY 2014Yearly · 2014-12-31 | Segment | All Other Segments | 525,000,000 | USD | 0001047469-17-000899 |
| FY 2014Yearly · 2014-12-31 | Segment | Global Health Benefits | 27,369,000,000 | USD | 0001047469-17-000899 |
| FY 2014Yearly · 2014-12-31 | Segment | Global Supplemental Benefits | 3,008,000,000 | USD | 0001047469-17-000899 |
| FY 2014Yearly · 2014-12-31 | Segment | Group Disability And Life | 3,992,000,000 | USD | 0001047469-17-000899 |
| FY 2013Yearly · 2013-12-31 | Segment | Corporate | -37,000,000 | USD | 0001047469-14-001502 |
| FY 2013Yearly · 2013-12-31 | Segment | Global Health Benefits | 25,296,000,000 | USD | 0001047469-14-001502 |
| FY 2013Yearly · 2013-12-31 | Segment | Global Supplemental Benefits | 2,639,000,000 | USD | 0001047469-14-001502 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.